Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL431430 | 0.88 | TDP1 (0.60) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Benzene SCHEMBL19063434 | 0.88 | TDP1 (0.60) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Pyridine SCHEMBL6742447 | 0.85 | TDP1 (0.56) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Pyridine SCHEMBL28738366 | 0.85 | TDP1 (0.56) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Pyridine SCHEMBL4778534 | 0.85 | TDP1 (0.56) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Pyridine SCHEMBL1819960 | 0.83 | TDP1 (0.47) | TDP1NAPRTTSHRALDH1A1HSD17B10 | |
| Pyridine SCHEMBL10678990 | 0.82 | NAPRT (0.53) | TDP1NAPRTTSHRALDH1A1 | |
| Pyridine SCHEMBL27323193 | 0.82 | NAPRT (0.53) | TDP1NAPRTTSHR | |
| Pyridine SCHEMBL28192777 | 0.82 | NAPRT (0.53) | TDP1NAPRTTSHRALDH1A1 | |
| Pyridine SCHEMBL546119 | 0.82 | NAPRT (0.53) | TDP1NAPRTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023098650-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 盖鑫 | 2023-06-08 | — | — | WO | claimed |
| CN-116196321-A | Application and preparation of bisepoxylignanoid compound and antiviral composition | 盖鑫 | 2023-06-02 | — | — | CN | claimed |
| US-8552219-B2 | Process for preparing L-phenyl-3-dimethylaminopropane derivative | IND-SWIFT LABORATORIES LIMITED (IN) | 2013-10-08 | — | — | US | claimed |
| EP-2619174-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | Ind-Swift Laboratories Limited (IN) | 2013-07-31 | — | — | EP | claimed |
| US-20130190522-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2013-07-25 | — | — | US | claimed |
| WO-2012038974-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2012-03-29 | — | — | WO | claimed |
| WO-2023098650-A1 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND | 盖鑫 | 2023-06-08 | — | — | WO | disclosed |
| CN-116196321-A | Application and preparation of bisepoxylignanoid compound and antiviral composition | 盖鑫 | 2023-06-02 | — | — | CN | disclosed |
| CN-114934286-A | Method for electrocatalytic carboxylic acid cyanidation | 中国农业大学 | 2022-08-23 | — | — | CN | disclosed |
| CN-113087763-A | Method for preparing cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-113004288-A | Method for preparing cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-108026103-B | Method for preparing cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2021-04-16 | — | — | CN | disclosed |
| CN-108290895-B | Process for preparing cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-1092413-A | The phenyloxazolidinone antibacterial agents that tropone replaces | UPJOHN CO (US) | 1994-09-21 | — | — | CN | disclosed |
| EP-0610265-A1 | SUBSTITUTED ARYL- AND HETEROARYLPHENYLOXAZOLIDINONES USEFUL AS ANTIBACTERIAL AGENTS. | UPJOHN CO (US) | 1994-08-17 | — | — | EP | disclosed |
| WO-1994013649-A1 | TROPONE-SUBSTITUTED PHENYLOXAZOLIDINONE ANTIBACTERIAL AGENTS | THE UPJOHN COMPANY (US) | 1994-06-23 | — | — | WO | disclosed |
| WO-1993023400-A1 | PENTACYCLIC ANTIHISTAMINES | SCHERING CORPORATION (US) | 1993-11-25 | — | — | WO | disclosed |
| CN-87105345-A | Tertiary amine compound | — | 1988-02-03 | — | — | CN | disclosed |
| US-3987082-A | PROSTAGLANDIN INTERMEDIATE | MERCK & CO., INC. (US) | 1976-10-19 | — | — | US | disclosed |
| US-3950359-A | PROSTAGLANDINS AND METHODS OF MAKING SAME | MERCK & CO., INC. (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190522-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | CYP3A43, UGT1A1, UGT1A7 | TDP1 1658/4885NAPRT 2225/4885TSHR 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.